Rocky mountain spotted fever characterization and comparison to similar illnesses in a highly endemic area - Arizona, 2002-2011

Clinical Infectious Diseases

Volumn 60, Issue 11, 2015, Pages 1650-1658

  Traeger, Marc S ^a   Regan, Joanna J ^b   Humpherys, Dwight ^a   Mahoney, Dianna L ^a   Martinez, Michelle ^a   Emerson, Ginny L ^c   Tack, Danielle M ^c,d   Geissler, Aimee ^e   Yasmin, Seema ^d   Lawson, Regina ^f   Hamilton, Charlene ^g   Williams, Velda ^g   Levy, Craig ^h   Komatsu, Kenneth ^h   McQuiston, Jennifer H ^b   Yost, David A ^a  

^a INDIAN HEALTH SERVICE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Poxvirus and Rabies Branch Division of High Consequence Pathogens and Pathogenicity NCEZID   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^f NORTH CAROLINA STATE UNIVERSITY   (United States)

^g U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^h Bureau of Epidemiology and Disease Control   (United States)

Author keywords

AIAN; American Indians; Rhipicephalus sanguineus; Rocky Mountain spotted fever; tick borne

Indexed keywords

DOXYCYCLINE; SODIUM; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; AMERICAN INDIAN; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL FEATURE; CLINICAL LABORATORY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; ENDEMIC DISEASE; FEMALE; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; ROCKY MOUNTAIN SPOTTED FEVER; SCHOOL CHILD; SODIUM BLOOD LEVEL; THROMBOCYTE COUNT; UNITED STATES; ANIMAL; ARIZONA; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTI-BACTERIAL AGENTS; ARIZONA; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TESTS, ROUTINE; DOXYCYCLINE; ENDEMIC DISEASES; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROCKY MOUNTAIN SPOTTED FEVER; YOUNG ADULT;

EID: 84930399374     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ115     Document Type: Article

References (34)

1. Demma LJ, Traeger MS, Nicholson WL, et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med 2005; 353:587-94.
2. Demma LJ, Eremeeva M, Nicholson WL, et al. An outbreak of Rocky Mountain spotted fever associated with a novel tick vector, Rhipicephalus sanguineus, in Arizona, 2004: preliminary report. Ann N Y Acad Sci 2006; 1078:342-3.
3. Maricopa County Department of Public Health. Rocky Mountain spotted fever fact sheet. Available at: http://www.maricopa.gov/publichealth/ Services/EPI/Diseases/rmsf/pdf/FactSheet.pdf. Accessed 24 February 2015.
4. Arizona Department of Health. Rocky Mountain spotted fever, Arizona statistics. Available at: http://www.azdhs.gov/phs/oids/vector/rmsf/stats. B. Accessed 24 February 2015.
5. Eremeeva ME, Zambrano ML, Anaya L, et al. Rickettsia rickettsii in Rhipicephalus ticks, Mexicali, Mexico. J Med Entomol 2011; 48:418-21.
6. Pacheco RC, Moraes-Filho J, Guedes E, et al. Rickettsial infections of dogs, horses and ticks in Juiz de Fora, southeastern Brazil, and isolation of Rickettsia rickettsii from Rhipicephalus sanguineus ticks. Med Vet Entomol 2011; 25:148-55.
7. Eremeeva ME, Bosserman E, Zambrano M, Demma L, Dasch GA. Molecular typing of novel Rickettsia rickettsii isolates from Arizona. Ann N Y Acad Sci 2006; 1078:573-7.
8. Demma LJ, Traeger M, Blau D, et al. Serologic evidence for exposure to Rickettsia rickettsii in eastern Arizona and recent emergence of Rocky Mountain spotted fever in this region. Vector Borne Zoonotic Dis 2006; 6:423-9.
9. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 2001; 184:1437-44.
10. Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006; 55(RR-4):1-27.
11. Regan JJ, Traeger M, Humpherys D. Risk factors for fatal outcome from Rocky Mountain spotted fever in a highly endemic area-Arizona, 2002-2011. Clin Infect Dis 2015; 60:1659-66.
12. National Center for Health Statistics. Healthy People 2010 final review. B 2012; 0-19. Available at: http://www.cdc.gov/nchs/data/ hpdata2010/hp2010-final-review.pdf. Accessed 24 February 2015.
13. Keppel K, Garcia T, Hallquist S, Ryskuklova A, Agress L. Comparing racial and ethnic populations based on Healthy People 2010 objectives. B People Stat Notes 2008; 26:1-16.
14. DuPont HL, Hornick RB, Dawkins AT, et al. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. J Infect Dis 1973; 128:340-4.
15. Hayes SF, Burgdorfer W. Reactivation of Rickettsia rickettsii in Dermacentor andersoni ticks: an ultrastructural analysis. Infect Immun 1982; 37:779-85.
16. Gilford JH, Price WH. Virulent-avirulent conversions of Rickettsia rickettsii in vitro. Proc Natl Acad Sci U S A 1955; 41:870-3.
17. Childs JE, Paddock CD. Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn? Am J Trop Med Hyg 2002; 66:450-7.
18. Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 3.5.3: a word processing, database, and statistic program for epidemiology on microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 2010.
19. Dalton MJ, Clarke MJ, Holman RC, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995; 52:405-13.
20. Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 1984; 150:480-8.
21. Buckingham SC, Marshall GS, Schutze GE, et al. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr 2007; 150:180-4, 184.e1.
22. Hayden AM, Marshall GS. Rocky Mountain spotted fever at Koair Children's Hospital, 1990-2002. J Ky Med Assoc 2004; 102:209-14.
23. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995; 20:1118-21.
24. Kirk JL, Fine DP, Sexton DJ, Muchmore HG. Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986. Medicine 1990; 69:35-45.
25. Wilfert CM, MacCormack JN, Kleeman K, et al. Epidemiology of Rocky Mountain spotted fever as determined by active surveillance. J Infect Dis 1984; 150:469-79.
26. Linnemann CC Jr, Janson PJ. The clinical presentations of Rocky Mountain spotted fever. Comments on recognition and management based on a study of 63 patients. Clin Pediatr 1978; 17:673-9.
27. National Notifiable Diseases Surveillance System (NNDSS). Rocky Mountain spotted fever (RMSF) (Rickettsia rickettsii). 2008 case definition. Available at: http://www.cdc.gov/NNDSS/script/casedef.aspx? CondYrID=828&DatePub=1/1/2008. Accessed 24 February 2015.
28. Openshaw JJ, Swerdlow DL, Krebs JW, et al. Rocky Mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg 2010; 83:174-82.
29. Holman RC, McQuiston JH, Haberling DL, Cheek JE. Increasing incidence of Rocky Mountain spotted fever among the American Indian population in the United States. Am J Trop Med Hyg 2009; 80: 601-5.
30. Dantas-Torres F. The brown dog tick, Rhipicephalus sanguineus (Latreille, 1806) (Acari: Ixodidae): from taxonomy to control. Vet Parasitol 2008; 152:173-85.
31. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. B Infect Dis 2007; 44:S27-72.
32. Eremeeva ME, Bosserman EA, Demma LJ, et al. Isolation and identification of Rickettsia massiliae from Rhipicephalus sanguineus ticks collected in Arizona. Appl Environ Microbiol 2006; 72:5569-77.
33. Garcia-Garcia JC, Portillo A, Nunez MJ, et al. A patient from Argentina infected with Rickettsia massiliae. Am J Trop Med Hyg 2010; 82:691-2.
34. Vitale G, Mansueto S, Rolain J-M, Raoult D. Rickettsia massiliae human isolation [letter]. Emerg Infect Dis 2006. Available at: http://dx.doi.org/ 10.3201/eid1201.050850. Accessed 24 February 2015.